研究者
J-GLOBAL ID:202301006964586299
更新日: 2025年02月23日 設樂 紘平
シタラ コウヘイ | Shitara Kohei
所属機関・部署: 職名:
科長
競争的資金等の研究課題 (2件): - 2022 - 2025 がん組織の空間的マルチスケール解析による免疫監視と免疫寛容制御機構の解明
- 2017 - 2022 トリプルネガティブ乳癌における免疫能を評価する新規亜分類と臨床的有用性の研究
論文 (81件): -
Hideaki Bando, Shogo Kumagai, Daisuke Kotani, Saori Mishima, Takuma Irie, Kota Itahashi, Yosuke Tanaka, Takumi Habu, Sayuri Fukaya, Masaki Kondo, et al. Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802). Nature cancer. 2025
-
Shigehiro Koganemaru, Shohei Koyama, Fumitaka Suto, Makito Koga, Koichiro Inaki, Yusuke Kuwahara, Takeo Arita, Tsuyoshi Hirata, Hiroki Goto, Naoya Wada, et al. The tumor immune microenvironment and therapeutic efficacy of trastuzumab deruxtecan in gastric cancer. Cancer research communications. 2024
-
Kohei Shitara, Kei Muro, Jun Watanabe, Kentaro Yamazaki, Hisatsugu Ohori, Manabu Shiozawa, Atsuo Takashima, Mitsuru Yokota, Akitaka Makiyama, Naoya Akazawa, et al. Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer. Nature medicine. 2024. 30. 3. 730-739
-
Tadayoshi Hashimoto, Yoshiaki Nakamura, Saori Mishima, Izuma Nakayama, Daisuke Kotani, Akihito Kawazoe, Yasutoshi Kuboki, Hideaki Bando, Takashi Kojima, Naoko Iida, et al. Whole-transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential. Cancer science. 2024
-
Shogo Takei, Yosuke Tanaka, Yi-Tzu Lin, Shohei Koyama, Shota Fukuoka, Hiroki Hara, Yoshiaki Nakamura, Yasutoshi Kuboki, Daisuke Kotani, Takashi Kojima, et al. Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer. Journal for immunotherapy of cancer. 2024. 12. 2
もっと見る MISC (18件): -
門田智裕, 小谷大輔, 依田雄介, 若林将史, 池野敬, 砂川弘憲, 中村能章, 川添彬人, 矢野友規, 設樂紘平. 進行胃がんに対するニボルマブとASP-1929を用いた光免疫療法の併用療法に関する第Ib相医師主導治験(GE-PIT). 日本レーザー医学会誌(Web). 2023. 44. 3
-
Takayuki Yoshino, Jun Watanabe, Kohei Shitara, Hirofumi Yasui, Hisatsugu Ohori, Manabu Shiozawa, Kentaro Yamazaki, Eiji Oki, Takeo Sato, Takeshi Naitoh, et al. Panitumumab (PAN) plus mFOLFOX6 versus bevacizumab (BEV) plus mFOLFOX6 as first-line treatment in patients with RAS wild-type (metastatic colorectal cancer (mCRC): Results from the phase 3 PARADIGM trial. JOURNAL OF CLINICAL ONCOLOGY. 2022. 40. 17
-
Satoshi Yuki, Yoshiaki Nakamura, Hiroya Taniguchi, Tadamichi Denda, Tomohiro Nishina, Yasuo Hamamoto, Hiroki Hara, Taito Esaki, Hisato Kawakami, Atsuo Takashima, et al. Expression of PD-L1 and PD-L2 in colorectal cancer (CRC): A post-hoc integrated analysis of SCRUM-Japan GI-SCREEN CRC. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 3
-
Tomohiro Kadota, Daisuke Kotani, Yusuke Yoda, Miki Fukutani, Masashi Wakabayashi, Shogo Nomura, Nozomu Fuse, Akihiro Sato, Tomonori Yano, Kohei Shitara. A phase Ib study of near infrared photoimmunotherapy (NIR-PIT) using ASP-1929 in combination with nivolumab and for patients with advanced gastric or esophageal cancer (GE-PIT study, EPOC1901). JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 4
-
Akihito Kawazoe, Shota Fukuoka, Yoshiaki Nakamura, Yasutoshi Kuboki, Yuichi Mikamoto, Hikari Shima, Noriko Fujishiro, Tsukiko Higuchi, Masashi Wakabayashi, Shogo Nomura, et al. An open-label phase II study of lenvatinib plus pembrolizumab in patients with advanced gastric cancer (EPOC1706). JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 4
もっと見る 前のページに戻る